GOLDMAN SACHS GROUP INC (GS) Stock News

Bogota Financial Corp. announced the execution of a merger agreement with GSL Savings Bank, expected to increase consolidated assets from $877.2 million to approximately $1.0 billion. The merger is anticipated to close in the second half of 2026 and is projected to be accretive to earnings per share and tangible book value. Frank Giancola, GSL's CEO, will become Executive Vice President and Chief Operating Officer of Bogota.

Rosen Law Firm is reminding investors in Regencell Bioscience Holdings Limited, ChampionX Corporation, and Commvault Systems, Inc. of upcoming lead plaintiff deadlines in securities class action lawsuits. The lawsuits allege that defendants made false or misleading statements regarding market manipulation vulnerabilities, regulatory risks, and other material misstatements that caused investor damages.

NEW YORK , May 29, 2026 /PRNewswire/ -- AllianceBernstein Global High Income Fund, Inc. (NYSE: AWF ), a registered closed‑end investment company, today announced earnings for the fourth quarter ended March 31, 2026. Total net assets of the Fund on March 31, 2026 were $963,393,828 as compared with $985,227,126 on December 31, 2025 and $966,409,431 on March 31, 2025. On March 31, 2026, the net asset value per share was $11.17 based on 86,229,677 shares of common stock outstanding. March 31, 2026 December 31, 2025 March 31, 2025 Total Net Assets $963,393,828 Full story available on Benzinga.com

FirstService Corporation announced that its subsidiary Century Fire Protection has acquired GSC Fire & Security (Austin, Texas) and Titan Fire Protection (Tampa, Florida). Both acquisitions expand Century's presence in the U.S. Sun Belt region and enhance its fire sprinkler and alarm service capabilities. The existing management teams of both businesses retained minority equity interests and will continue operations.

<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <ul> <li style="list-style-type:none;"> <ul> <li style="text-align:left;"><strong>Total sales increased 14%, on top of 6% last year </strong></li> <li style="text-align:left;"><strong>Comparable store sales increased 6%</strong></li> <li style="text-align:left;"><strong>Net income was $115 million, and diluted EPS was $1.79 </strong></li> <li style="text-align:left;"><strong>Excluding certain expenses associated with bankruptcy acquired leases: </strong> <ul> <li><strong>Adjusted EPS increased 26% to $2.10, well above guidance</strong></li> <li><strong>Full year adjusted EPS guidance is now $11.45 to $11.80<br /><br /></strong></li> </ul> </li> </ul> </li> </ul> <p align="left">BURLINGTON, N.J., May 28, 2026 (GLOBE NEWSWIRE) -- Burlington Stores, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/quote/BURL" rel="nofollow">BURL</a>), a nationally recognized off-price retailer of high-quality, branded apparel, footwear, accessories, and merchandise for the home at everyday low prices, today announced its results for the first quarter ended May 2, 2026.</p> <p align="left">Michael O'Sullivan, CEO, stated, "We are pleased with our strong performance in the first quarter. Adjusted EPS grew 26% versus the first quarter of last year, which represented our 14th consecutive quarter of double digit EPS growth. This track record demonstrates our ability to consistently convert sales into operati

Rosen Law Firm has filed securities class action lawsuits against Regencell Bioscience Holdings Limited, FS KKR Capital Corp., and New Era Energy & Digital, Inc. Investors who purchased securities during specified class periods and suffered losses exceeding $100,000 are encouraged to join the litigation before upcoming deadlines. The lawsuits allege false and misleading statements regarding market manipulation, regulatory risks, and financial disclosures.

GeneDx Holdings stock plummeted 49% on May 5, 2025, after the company reported a massive Q1 2026 earnings miss, a tenfold increase in net loss, and significantly reduced full-year guidance. The company's average reimbursement rate fell short of expectations due to an adverse shift in product mix toward lower-margin genome tests. Hagens Berman has opened an investigation into potential securities law violations regarding whether management misled investors about product mix changes and growth projections.

SINGAPORE , May 27, 2026 /PRNewswire/ -- Noah Holdings Limited ("Noah" or the "Company") (NYSE: NOAH ), a leading and pioneer wealth management service provider offering comprehensive one-stop advisory services on global investment and asset allocation primarily for global Chinese high-net-worth investors, anno unced its unaudited financial results for the first quarter of 2026. FIRST QUARTER 2026 FINANCIAL HIGHLIGHTS Net revenues for the first quarter of 2026 were RMB625.8 million (US$90.7 million), a 1.8% increase from the corresponding period in 2025, primarily due to an increase in performance-based income from domestic private secondary products, partially offset by a decrease in one-time commissions from insurance products, and a 14.7% decrease quarter-on-quarter, primarily due to a decrease in performance-based income from overseas private equity products as compared with the fourth quarter of 2025. Income from operations for the first quarter of 2026 was RMB236.4 million (US$34.3 million), a 27.1% increase from the corresponding period in 2025, primarily due to disciplined cost control on employee compensation. Net income attributable to Noah shareholders for the first quarter of 2026 was RMB124.7 million (US$18.1 million), a 16.3% decrease from the corresponding period in 2025, primarily due to a higher loss from equity in affiliates, partially offset by lower operating costs and expenses. Non-GAAP [1] net income attributable to Noah shareholders for the first quarter of 2026 was RMB133.9 million (US$19.4 million), a 20.7% decrease from the corresponding period in 2025. FIRST QUARTER 2026 OPERATIONAL UPDATES The Company reports its operational performance across six business segments — three domestic and three overseas — plus headquarters. The following updates provide segment-specific operating metrics and developments during the first quarter of 2026. Group

TGS has been awarded a large 4D streamer contract offshore Angola, with acquisition scheduled to commence in early July 2026 for approximately 8 months. The contract reinforces TGS' strategic position in Africa and provides vessel visibility into Q1 2027, utilizing their advanced Ramform acquisition platform and GeoStreamer technology.

Austin, Texas , May 26, 2026 (GLOBE NEWSWIRE) -- FOR IMMEDIATE RELEASE MEDX HOLDINGS (MEDH) REPORTS EXCEPTIONAL Q1 2026 FINANCIALS: REVENUE SURGES, EXPANSION ON TRACK, AND CEO TO SPEAK AT HEMP BEVERAGE EXPO AUSTIN, Texas — May 26, 2026 — MedX Holdings, Inc. (OTC: MEDH ) (soon to be Dazed Inc., pending ticker symbol DAZE), a dynamic brands and acquisition company focused on the emerging hemp, cannabis, and hospitality industries, today announced its financial results for the first quarter ended March 31, 2026. The company is thrilled to report significant year-over-year revenue and gross profit growth, continued profitability, and major traction in its nationwide franchise expansion. Q1 2026 Financial Highlights: Accelerated Growth and Profitability The first quarter of 2026 reflects the power of MedX's strategic focus on high-margin branding, efficient operations, and calculated expansion. Key financial milestones from the Q1 2026 consolidated financial statements include: Solid Revenue Growth: Q1 2026 revenues reached $521,874, representing an impressive 52.7% increase compared to revenues of $341,711 in Q1 2025. Surging Gross Profit: Gross profit for the quarter climbed to $398,990, a 70.6% jump from the $233,793 reported in the same period last year. Sustained Profitability: The company maintained a positive bottom line, reporting a net income of $22,203 for the three months ended March 31, 2026. Expansion on Track: Bringing the "Third Place" to New Cities Following the momentum built in late 2025, ... Full story available on Benzinga.com

Rosen Law Firm is urging investors who purchased Upstart Holdings (NASDAQ: UPST) securities between May 14, 2025 and November 4, 2025 to join a class action lawsuit. The lawsuit alleges that Upstart made false statements about its Model 22 AI risk assessment tool, claiming it frequently overreacted to negative economic signals, overstated accuracy, and negatively impacted revenue guidance. The lead plaintiff deadline is June 8, 2026.

MedX Holdings announced Q1 2026 results with continued net profitability and debt reduction. The company is rebranding to Dazed Inc. (ticker: DAZE) and expanding with three new LazyDaze + Coffeeshop locations in San Marcos, Houston, and Baltimore. The company is also finalizing partnerships for Lazydaze Coffee and K-Cup products and capitalizing on cannabis's federal reclassification to Schedule III.

Austin, Texas, May 22, 2026 (GLOBE NEWSWIRE) -- MEDX HOLDINGS ANNOUNCES Q1 2026 HIGHLIGHTS, MULTI-CITY EXPANSION, AND CORPORATE ACTION TO REBRAND AS DAZED INC. (TICKER: DAZE) AUSTIN, Texas — May 22, 2026 — MedX Holdings, Inc. (OTC: MEDH ), a leader in the converging cannabis, hemp, and hospitality sectors, today announced its operational and financial highlights for the first quarter of 2026. Building on the net profitability achieved in Q4 2025, the company continues to execute its aggressive expansion strategy, marked by upcoming store openings, strategic product partnerships, and a major corporate rebranding initiative to align with its rapidly growing consumer footprint. Corporate Action: Rebranding to Dazed Inc. To align the company's corporate identity with its flagship consumer brands and long-term vision, MedX Holdings has announced its intention and initiated the required corporate actions to change its name to Dazed Inc. Alongside this name change, the company intends to request a formal ticker symbol change to DAZE . This strategic evolution reflects the company's dominant focus on scaling the Lazydaze franchise ecosystem and Dazed Distribution networks. Q1 Financial and Operational Milestone Highlights Continued Debt Reduction: MedX sustained its disciplined focus on balance sheet strength, further paring down long-term liabilities throughout Q1 to enhance cash flow and shareholder equity. Lazydaze Coffee & K-Cup Partnerships: The company is currently in the final stages of talks with potential strategic partners to massively scale ... Full story available on Benzinga.com

CHARLOTTE, N.C. , May 21, 2026 /PRNewswire/ -- The Cato Corporation (NYSE: CATO ) today reported net income of $9.3 million or $0.47 per diluted share for the first quarter ended May 2, 2026, compared to net income of $3.3 million or $0.17 per diluted share for the first quarter ended May 3, 2025. Sales for the first quarter ended May 2, 2026 were $169.5 million, or an increase of 0.7% from sales of $168.4 million for the first quarter ended May 3, 2025. The Company's same-store sales for the quarter increased 3%. "Our results significantly benefited from the refund claim of IEEPA (International Emergency Economic Powers Act) tariffs in the quarter. Our sales trend softened as the quarter continued in part due to higher fuel prices pressuring our customers' discretionary income," said John Cato, Chairman, President and Chief Executive Officer. " For the foreseeable future we expect our sales to be negatively impacted by rising inflation, especially fuel and food prices, which will reduce our customers' discretionary income." First quarter gross margin as a percentage of sales was 37.2% in 2026 and 35.1% in 2025. The increase in gross margin as a percentage of sales is due in part to a pre-tax $5.7 million tariff refund claim partially offset by lower merchandise contribution caused in part by higher sales of marked-down goods. Selling, General and Administrative expense decreased to $53.9 million in the first quarter of 2026 from $55.3 million in 2025 due to decreases in corporate payroll expense, insurance costs and equipment maintenance partially offset by incentive compensation expense. Selling, General and Administrative expense as a percentage of sales decreased to 31.8% in 2026 compared to 32.8% in 2025. Interest and other income were $1.2 million in both 2026 and 2025. Income tax expense for the quarter decreased to $0.5 million in 2026 from $0.9 million in 202

A class action lawsuit has been filed against Upstart Holdings, Inc. for allegedly making false and misleading statements about its Model 22 AI risk assessment tool. The lawsuit claims the model frequently overreacted to negative macroeconomic signals, overstated accuracy, and negatively impacted revenue results, rendering the company's 2025 guidance unreliable. Investors who purchased Upstart securities between May 14, 2025 and November 4, 2025 can seek damages.

<p xmlns="http://www.w3.org/1999/xhtml" class="prntac"><b xmlns="http://www.w3.org/1999/xhtml">— Diluted EPS of $2.90; Adjusted Diluted EPS</b><b xmlns="http://www.w3.org/1999/xhtml"><sup xmlns="http://www.w3.org/1999/xhtml">1</sup></b><b xmlns="http://www.w3.org/1999/xhtml"> of $3.03 —<br xmlns="http://www.w3.org/1999/xhtml" /></b><b xmlns="http://www.w3.org/1999/xhtml">— Comparable Sales increased 0.6% — <br xmlns="http://www.w3.org/1999/xhtml" /></b><b xmlns="http://www.w3.org/1999/xhtml">— Affirms Full Year 2026 Outlook —</b></p> <p xmlns="http://www.w3.org/1999/xhtml" id="temp_ReleaseStart"><span xmlns="http://www.w3.org/1999/xhtml" class="legendSpanClass">MOORESVILLE, N.C.</span>, <span xmlns="http://www.w3.org/1999/xhtml" class="legendSpanClass">May 20, 2026</span> /PRNewswire/ -- Lowe's Companies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/quote/LOW" rel="nofollow">LOW</a>) today reported net earnings of $1.6 billion and diluted earnings per share (EPS) of $2.90 for the quarter ended May 1, 2026, compared to diluted EPS of $2.92 in the first quarter of 2025. During the first quarter, the company recognized $96 million in pre-tax expenses associated with the acquisitions of Foundation Building Materials (FBM) and Artisan Design Group (ADG). Excluding these expenses, first quarter 2026 adjusted diluted EPS<sup xmlns="http://www.w3.org/1999/xhtml">1</sup> increased 3.8% to $3.03 compared to the prior-year diluted EPS.</p> <div xmlns="http://www.w3.org/1999/xhtml" class="P

Law firm Bragar Eagel & Squire is investigating GeneDx Holdings Corp. for potential securities law violations following the company's May 4, 2026 earnings report that revealed a $57.5 million operational loss, $65 million revenue guidance cut, and a $31.3 million goodwill write-down. GeneDx shares plummeted 50% from $67.93 to $34.51 on the news, citing lower-than-expected reimbursement rates and weak performance from its Fabric Genomics unit.

BOSTON , May 19, 2026 /PRNewswire/ - The John Hancock Closed-End Funds listed in the table below announced earnings 1 for the three months ended April 30, 2026. The same data for the comparable three-month period ended April 30, 2025 is also available below. Three Months Ended 04/30/2026 Ticker Fund Name Current Fiscal Year End Net Investment Income Per Common Share NAV Total Managed Assets Total Net Assets HPI Preferred Income Fund 7/31 $ 7,535,537 $ 0.281 $15.74 $ 678,919,741 * $ 421,819,741 HPF Preferred Income Fund II 7/31 $ 6,108,284 $ 0.282 $15.59 $ 544,450,049 * $ 337,750,049 HPS Preferred Income Fund III 7/31 $ 8,158,019 $ 0.253 $14.04 $ 726,239,214 * $ 451,939,214 JHS Income Securities Trust 10/31 $ 1,784,360 $ 0.153 $12.21 $ 233,450,409 * $ 142,150,409 JHI Investors Trust 10/31 $ 2,679,597 $ 0.306 $14.61 $ 214,681,835 * $ 127,781,835 Full story available on Benzinga.com

GeneDx Holdings Corp. (NASDAQ: WGS) faces a securities investigation following disappointing Q1 2026 results, including a $57.5 million operating loss, $65 million revenue guidance cut, and a $31.3 million goodwill write-down for its Fabric Genomics unit. The stock plummeted 50% from $67.93 to $34.51 on May 5, 2026, following the May 4 earnings announcement.

CALGARY, AB, May 17, 2026 (GLOBE NEWSWIRE) -- Seegnal Inc. (TSXV: SEGN ) (" Seegnal " or the " Company ") announces that the management cease trade order (the " MCTO "), issued by the Alberta Securities Commission on May 8, 2026, at the request of the Company, will no longer be in effect as of May 16, 2026. On May 13, 2026, the Company filed its audited consolidated financial statements for the year ended December 31, 2025, together with the related management's discussion and analysis and the Chief Executive Officer and the Chief Financial Officer certifications. The MCTO applied only to the Chief Executive Officer and the Chief Financial Officer and did not affect the ability of the general investing public to trade in the Company's securities. The Company confirms that it is current with its continuous disclosure obligations and anticipates meeting its future filing requirements. About Seegnal Seegnal is a public company that aims to solve one of the top causes of death and injuries in the modern world – Adverse Drug Effects (ADEs). Seegnal's Clinical Decision Support system introduces a paradigm shift in the approach to this problem by implementing a new elevated Patient-Centric Standard. Seegnal's SaaS technology exclusively integrates at the point-of-care, unique patient-specific data like genetics, results of lab tests, ECG, smoking, allergies, food, gender, age, and the effects of many concomitant medications, while reducing the current alert load for clinicians ... Full story available on Benzinga.com

GeneDx Holdings Corp. (NASDAQ: WGS) faces a securities investigation following disappointing Q1 2026 results, including a $57.5 million operating loss, $65 million revenue guidance cut, and a $31.3 million goodwill write-down for its Fabric Genomics unit. The stock plummeted 50% from $67.93 to $34.51 on May 5, 2026, following the May 4 earnings announcement.

Brookfield Bancshares, Inc. and First National Bank of Brookfield announced the execution of a definitive merger agreement to acquire NSTS Bancorp, Inc. and North Shore Trust and Savings in an all-cash transaction valued at approximately $73.7 million. NSTS stockholders will receive $14.28 per share in cash. The transaction is expected to close in Q4 2026, subject to regulatory approvals and stockholder approval. Post-closing, the combined entity will operate four branches in the Chicago-Naperville-Elgin MSA with over $600 million in assets.

Vinci Compass Investments (NASDAQ:VINP) reported strong first quarter 2026 results with record Fee Related Earnings of R$96.3 million (R$1.47 per share) and a 35.4% FRE margin. The company declared a quarterly dividend of US$0.17 per share and highlighted contributions from Verde integration, fundraising momentum, and expansion through the announced BACS combination in Argentina.

GSK entered an exclusive strategic collaboration with Sino Biopharmaceutical to accelerate bepirovirsen, an investigational hepatitis B treatment, in mainland China. The drug is under priority regulatory review in China and showed positive Phase 3 trial data. GSK will retain marketing authorization and regulatory responsibility while CTTQ handles distribution and promotional activities. Additionally, GSK announced the final tranche of its £2 billion share repurchase program.

Rosen Law Firm reminds zSpace Inc. (NASDAQ: ZSPC) investors of the June 22, 2026 lead plaintiff deadline in a securities class action lawsuit. The lawsuit alleges that zSpace's Registration Statement contained false and misleading statements regarding undisclosed preferred shareholders and potential litigation risks that were downplayed in risk disclosures at the time of the December 2024 IPO.